Updated: 07/11/2014 6:16 PM
Created: 07/11/2014 12:01 PM WDIO.com
By: MATTHEW PERRONE, AP Health Writer
WASHINGTON (AP) - Federal health advisers say there is little to no evidence that a popular technique for removing fibroids can be performed without the risk of spreading undetected cancers to other parts of the body.
The panel of Food and Drug Administration experts also said Friday that women who do undergo the procedure should sign a written consent form stating they understand the serious risks of laparoscopic power morcellation, in which electronic tools are used to grind tissue and remove it through a small incision in the abdomen.
Surgeons developed the technique as an alternative to traditional surgery, which requires a larger incision that often results in more bleeding and longer hospital stays. But the FDA convened a two-day meeting this week after concluding that the risk of accidentally spreading undetected cancer to other organs may be far more common than previously thought.
The agency asked its panel of obstetrics and gynecology experts to weigh in on potential methods for minimizing the risk, including using plastic specimen bags to catch bits of shredded tissue. Some surgeons already use that technique, but panelists said it is based on "intuition."
"There's no evidence that the bags or any containment devices prevent the outcome we are trying to prevent," said Dr. Craig Shriver of the Walter Reed Medical Center.
The panel also discussed the difficulties of screening women for a rare form of uterine cancer, called leiomyosarcoma, ahead of the procedure. Imaging techniques are often unable to distinguish between the cancers and normal fibroids. And while there are some common risk factors - based on women's age, race and family history - panelists said they are not reliable.
"It doesn't sound like anyone has confidence that those will be able to predict the vast majority of leiomyosarcomas," said Dr. Michael Diamond, of Georgia Regents University.
The FDA takes the opinions of its panelists into consideration when it makes regulatory decisions on medical devices and other treatments. The agency has not set a timeline for taking action on power morcellators.
Doctors have long acknowledged the risk of accidentally spreading undetected cancer with such electronic shredding tools. But in April the FDA said doctors should halt use of the devices for fibroid treatments after agency scientists calculated that the risk of cancer spread was greater than previously thought. The agency estimated as many as 1 in 350 women may have undetected uterine cancer that can be ruptured by the technique. Previous estimates put the rate closer to 1 in 7,000
Earlier in the day cancer patients and family members of deceased patients urged the FDA to ban the use of electronic surgical tools for fibroid removal.
"Would you permit your wife or sister to undergo a procedure that has a one in 351 chance of spreading cancer throughout the body?" Colleen Daley asked the FDA panel. Daley's sister, Patricia Marie Daley, died in 2011 of leiomyosarcoma that spread to her lungs after undergoing treatment via power morcellation.
The FDA approved the first electronic morcellators in 1995 and about two dozen have been approved in U.S. since then. The devices were cleared through an abbreviated review process because they were deemed similar to manual surgical devices long on the market.
Fibroids are non-cancerous growths in the uterus that can cause severe pain, heavy bleeding, and bladder and bowel dysfunction, mostly among women in their late 30s and 40s. It's unclear what causes the tumor-like growths - which can grow as large as cantaloupes - but they account for an estimated 240,000 of the 600,000 annual hysterectomies in the U.S. At least 50,000 U.S. women undergo hysterectomy using the power morcellation technique.
Hysterectomy is a key treatment because it is the only way to ensure that fibroids do not return. Myomectomy, surgery that removes fibroids while leaving the uterus intact, is recommended for women who still want to become pregnant.
(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
New York Officials: Doctor has Ebola, 1st in City
A Doctors Without Borders physician who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus, according to preliminary test results, city officials said Thursday. He's the fourth confirmed case in the U.S. and the first in the nation's biggest city.
Minn. Officials Walk Through Mock Ebola Scenario
More than 100 representatives from several Minnesota agencies are going through a mock exercise to review the state's preparedness in the event of a case of Ebola.
Woman Charged with Murder after Stabbing in Stoney Brook Township
There is new development in the murder case on the Fond du Lac Reservation. The husband of the victim has been released, and he is facing no charges. Instead, the woman who police had been searching for, Lydia Marie Barney, has been charged with second degree murder.
No Injuries in Early Morning Esko Structure Fire
Deputies say there were no injuries in an early morning structure fire in Esko Thursday. Crews responded to the 200 block of Nelson Road around 4:30 a.m. Deputies said the cause of the fire was not suspicious.
1 Dead, 1 Arrested in Cass County Crash
An Aitkin County man is in custody and another person is dead after a two-vehicle head-on collision in Cass County.